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The CaaX tetrapeptide motif typically directs three sequential posttranslational modifications, namely,
isoprenylation, proteolysis, and carboxyl methylation. In all eukaryotic systems evaluated to date, two CaaX
proteases (Rce1 and Ste24/Afc1) have been identified. Although the Trypanosoma brucei genome also encodes
two putative CaaX proteases, the lack of detectable T. brucei Ste24 activity in trypanosome cell extracts has
suggested that CaaX proteolytic activity within this organism is solely attributed to T. brucei Rce1 (J. R.
Gillespie et al., Mol. Biochem. Parasitol. 153:115–124. 2007). In this study, we demonstrate that both T. brucei
Rce1 and T. brucei Ste24 are enzymatically active when heterologously expressed in yeast. Using a-factor and
GTPase reporters, we demonstrate that T. brucei Rce1 and T. brucei Ste24 possess partially overlapping
specificities much like, but not identical to, their fungal and human counterparts. Of interest, a CaaX motif
found on a trypanosomal Hsp40 protein was not cleaved by either T. brucei CaaX protease when examined in
the context of the yeast a-factor reporter but was cleaved by both in the context of the Hsp40 protein itself when
evaluated using an in vitro radiolabeling assay. We further demonstrate that T. brucei Rce1 is sensitive to small
molecules previously identified as inhibitors of the yeast and human CaaX proteases and that a subset of these
compounds disrupt T. brucei Rce1-dependent localization of our GTPase reporter in yeast. Together, our
results suggest the conserved presence of two CaaX proteases in trypanosomatids, identify an Hsp40 protein
as a substrate of both T. brucei CaaX proteases, support the potential use of small molecule CaaX protease
inhibitors as tools for cell biological studies on the trafficking of CaaX proteins, and provide evidence that
protein context influences T. brucei CaaX protease specificity.
Certain isoprenylated proteins are synthesized as precursors
having a highly degenerate C-terminal tetrapeptide CaaX mo-
tif (C, cysteine; a, aliphatic amino acid; X, one of several amino
acids). This motif typically directs three posttranslational mod-
ifications that include covalent attachment of an isoprenoid
lipid to the cysteine residue, followed by endoproteolytic re-
moval of the terminal three residues (i.e., aaX), and lastly,
carboxyl methyl esterification of the farnesylated cysteine (49,
50). Relevant examples of proteins subject to the above mod-
ifications, also referred to as CaaX proteins, include the Ras
and Ras-related GTPases, G subunits, prelamin A, members
of the Hsp40 family of chaperones, and fungal mating phero-
mones.
Isoprenylation of CaaX proteins is performed by either the
farnesyltransferase (FTase) or the geranylgeranyl transferase I
(GGTase I). The particular isoprenoid attached, C15 farnesyl
or C20 geranylgeranyl, respectively, depends in part on the
sequence of the CaaX motif (8, 26, 31). Proteolysis of isopre-
nylated intermediates is carried out by the otherwise unrelated
Rce1p (Ras converting enzyme 1) and Ste24p (sterile mutant
24) enzymes, collectively referred to as CaaX proteases, which
are integral membrane proteins residing within the endoplas-
mic reticulum (3, 40, 45). Studies to elucidate the specificities
of the CaaX proteases have often involved reporters designed
from biological substrates (e.g., Ras GTPases) (2, 3, 16, 21, 22,
24, 34). Although these studies suggest that isoprenylated
CaaX tetrapeptides alone are sufficient for recognition as a
substrate, insufficient evidence exists to assert whether this
sequence contains all of the necessary information for sub-
strate specificity. Reporters are typically cleaved by either
Rce1p or Ste24p. The Saccharomyces cerevisiae a-factor mating
pheromone is a rather unusual biological reporter since it is
cleaved by both yeast CaaX proteases. Orthologs of the CaaX
proteases from humans, worms, and plants can also cleave
a-factor when heterologously expressed in yeast, thereby mak-
ing a-factor a convenient reporter for comparative analyses of
CaaX protease activities (3, 5, 6, 36). Where evaluated using
the a-factor reporter, Rce1p and Ste24p display partially over-
lapping target specificity, and this is an expected property of
CaaX proteases in all eukaryotic systems (5, 6, 36, 47). Unlike
the isoprenylation and proteolysis steps, carboxyl methyl ester-
ification exclusively relies on a single enzyme, the isoprenyl-
cysteine carboxyl methyltransferase (ICMT) (23, 50). A farne-
sylated cysteine appears to be the sole recognition determinant
of the endoplasmic reticulum-localized ICMT (10, 23, 38).
Disruption of the posttranslational modifications associated
with CaaX proteins is often perceived as an anticancer strategy
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because of the prominent role of CaaX proteins in cellular
transformation (i.e., the Ras GTPases) (49). To date, the most
advanced drug discovery efforts have focused on farnesyltrans-
ferase inhibitors (FTIs) (9, 53). Inhibitors of the CaaX pro-
teases and ICMT are also being developed (1, 11, 28, 37, 39,
48). Disrupting CaaX protein modifications has therapeutic
application to other diseases as well. The relief of prelamin A
toxicity by FTIs is a well-documented example (51). Accumu-
lation of the farnesylated but unproteolysed precursor of lamin
A results in a progeroid phenotype in individuals lacking Zmp-
Ste24 proteolytic activity. The treatment of parasitic disease is
another area under investigation (13). A number of FTIs have
been developed that inhibit protozoan FTases, and in vivo
testing is a continued effort (15, 32). Although research is less
advanced with respect to CaaX protease and ICMT inhibitors,
RNA interference experiments on the bloodstream form of
Trypanosoma brucei indicate that CaaX processing enzymes
are required for viability and proliferation of the parasite (20).
In the present study, we evaluated the enzymatic properties
of the trypanosomal CaaX proteases. We establish through the
use of a variety of in vivo and in vitro assays that T. brucei Rce1
and T. brucei Ste24 are active when heterologously expressed
in S. cerevisiae and have partially overlapping substrate speci-
ficities. The assays rely on various reporters, specifically the
yeast a-factor mating pheromone, a K-Ras4B-based fluoro-
genic peptide, a green fluorescent protein (GFP)-GTPase fu-
sion, and a T. brucei Hsp40 protein. All but the GTPase re-
porter could be effectively cleaved by both T. brucei CaaX
proteases. We also demonstrate that the trypanosomal CaaX
proteases can be targeted for inhibition by small molecules
both in vitro and when heterologously expressed in yeast, sug-
gesting that the trypanosomal CaaX proteases may be attrac-
tive drug targets for pharmacological inhibition.
MATERIALS AND METHODS
Yeast strains and media. The yeast strains used in the present study are listed
in Table 1. To assess in vivo T. brucei CaaX protease function, strains EG123
(ATCC 204278; MATa trp1 leu2 ura3 his4 can1), IH1793 (ATCC 204279; MAT
lys1), and yWS164 (MATa trp1 leu2 ura3 his4 can1 mfa1-1 mfa2-1 rce1::TRP1
ste24::Kanr) were transformed with the appropriate plasmids (36). For isolation
of membranes enriched for T. brucei CaaX proteases, the strain used was
SM3614 (MATa trp1 leu2 ura3 his4 can1 rce1::TRP1 ste24::LEU2) transformed
with the appropriate plasmid (45). This strain was also used for purification of
heterologously expressed GST-Tbj1. To assess T. brucei Hsp40 function in vivo,
strains BY4741 (MATa his3 leu2 met15 ura3) and a BY4741 derivative (MATa
his3 leu2 met15 ura3 ydj1) were obtained from the yeast haploid knockout
collection (Research Genetics, Inc.) (19).
Plasmid-transformed strains were created according to published methods
(14). Unless otherwise noted, strains were routinely cultured at 30°C using yeast
extract-peptone-dextrose (YEPD) or synthetic complete dropout (SC) me-
dium as previously described (25). Where temperature sensitivity was evaluated,
yeast were simultaneously grown at 25 and 35.5°C for 3 and 2 days, respectively,
on YEPD solid medium. Experiments involving galactose-induced GFP-Ras2p
and GST-Tbj1 expression used synthetic media lacking glucose and uracil but
containing 2% galactose, 1% glycerol, and 1% ethanol (SGalura).
Plasmids. The plasmids used in the present study are listed in Table 2. Yeast
expression plasmids encoding T. brucei Rce1 (pWS766) and T. brucei Ste24
(pWS767) were created by PCR-directed recombination-mediated plasmid con-
struction (33). In brief, the open reading frames (ORFs) of T. brucei Rce1 and
T. brucei Ste24 (accession nos. XP_843748 and XP_827211, respectively) were
used to replace the ORFs of yeast RCE1 and STE24 encoded in pWS479 and
pWS154, respectively (36, 45). The trypanosomal ORFs were amplified by PCR
from T. brucei brucei genomic DNA (TREU 927). The appropriate PCR product
was cotransformed into yeast with pWS479 or pWS154 that had been linearized
with SphI and BglII/NotI, respectively, within the CaaX protease ORF. To
facilitate recombination between PCR products and linearized plasmids, the
PCR products were engineered to contain 39-bp extensions homologous to
sequences immediately 5 and 3 of the yeast ORFs encoded in pWS479 and
pWS154. The transformed yeast were plated on selective medium (SCura) to
allow for growth of cells that had formed a circularized plasmid; a linearized
plasmid is inefficiently propagated and does not support colony growth on se-
lective media. Independent plasmids were isolated from yeast colonies, reampli-
fied in E. coli, and subjected to restriction digest analysis and sequencing to verify
the presence and sequence of the trypanosomal ORF.
The process described above was used to create site-directed mutants of T.
TABLE 1. Yeast strains used in this study
Strain Genotypea Reference
BY4741 MATa his3 leu2 met15 ura3 19
EG123 MATa trp1 leu2 ura3 his4 can1 43
IH1793 MAT lys1 30
SM3614 MATa trp1 leu2 ura3 his4 can1 rce1::TRP1
ste24::LEU2
45
yWS164 MATa trp1 leu2 ura3 his4 can1 mfa1-1
mfa2-1 rce1::TRP1 ste24::Kanr
6
yWS304 MATa his3 leu2 met15 ura3 ydj1 19
a All strains are isogenic except BY4741 and yWS304, which are a separate
isogenic pair.
TABLE 2. Plasmids used in this study
Plasmid Genotype Source orreference
pRS315 CEN LEU2 42
pRS316 CEN URA3 42
pSM1107 CEN URA3 HA-STE24 18
pSM1282 2 URA3 PPGK 10HIS-HA-STE24 46
pSM1314 CEN URA3 RCE1-HA 40
pSM1317 2 URA3 STE14 38
pSM1585 2 URA3 HsHA-STE24 36
pSM1605 2 URA3 MFA1 41
pWS28 2 URA PPGK 52
pWS335 2 URA3 PPGK HIS-HA-HsRce122 36
pWS338 2 URA3 leu2-d PCUP1GST-YDJ1 29
pWS438 2 LEU2 MFA1 6
pWS439 2 LEU2 MFA1(CAMQ) This study
pWS440 2 LEU2 MFA1(CASQ) 6
pWS441 2 LEU2 MFA1(CTLM) 6
pWS442 2 LEU2 MFA1(CTVM) This study
pWS479 2 URA3 PPGK RCE1-HAc 36
pWS523 CEN URA3 PGAL GST-Ydj1 19
pWS750 CEN LEU2 PGAL GFP-RAS2 28
pWS766 2 URA3 PPGKTbRce1-HA This study
pWS767 2 URA3 PPGK His-HA-TbSte24 This study
pWS773 2 LEU2 MFA1(CTML) This study
pWS774 2 LEU2 MFA1(CVIM) This study
pWS775 2 LEU2 MFA1(CTQQ) This study
pWS776 2 LEU2 MFA1(CVHQ) This study
pWS782 2 URA3 leu2-d PCUP1 GST-Tbj1 This study
pWS783 2 URA3 leu2-d PCUP1 GST-Tbj1(C401S) This study
pWS798 2 URA3 PPGK TbRce1(E151A)-HA This study
pWS838 2 URA3 PPGK TbRce1(H184A)-HA This study
pWS800 2 URA3 PPGK TbRce1(H254A)-HA This study
pWS801 2 URA3 PPGK His-HA-TbSte24(H286A) This study
pWS805 2 URA3 PPGK His-HA-TbSte24(E287A) This study
pWS802 2 URA3 PPGK His-HA-TbSte24(H290A) This study
pWS880 2 LEU2 MFA1(CTAQ) This study
pWS888 2 URA3 PPGK Tbj2 This study
pWS889 2 URA3 PPGK Tbj3 This study
pWS890 2 URA3 PPGK Tbj4 This study
pWS900 CEN URA3 PGAL GST-Tbj1 This study
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brucei Rce1 and T. brucei Ste24. To create the T. brucei Rce1 mutants, pWS766
was linearized with either AatII or BglII, as appropriate. Creation of T. brucei
Ste24 mutants relied on SacI digestion of pWS767. To facilitate identification of
plasmid candidates for sequencing, the oligonucleotides used for PCR were
engineered to contain the intended mutation and a silent restriction site near the
mutational site.
Yeast expression plasmids encoding a-factor CaaX variants were also created
by recombination-based plasmid construction. In most instances, PstI and MluI
gapped pWS654 was used as the recipient vector for PCR products amplified
from pWS438 (6). The PCR products contained regions of 5 and 3 homology
for recombination, the desired mutation, and a silent restriction site that was
used to facilitate identification of the appropriate recombinant clone for confir-
matory DNA sequencing. The a-factor variants containing CAMQ and CTVM
motifs were constructed in two steps. First, intermediate plasmids were created
by recombination of MluI-gapped pSM1605 with PCR products amplified from
pSM1605 using mutagenic oligonucleotides. The resultant plasmids were then
modified by standard methods to replace the existing URA3 marker with LEU2.
Constructs encoding glutathione S-transferase (GST)–Tbj1 (pWS782) and
GST-Tbj1(C401S) (pWS783) behind the constitutive CUP1 promoter were cre-
ated by replacement of YDJ1 with Tbj1 using recombination within a GST-YDJ1
expression construct (pWS338) recovered from a GST fusion library (29). To
facilitate recombination, pWS338 was linearized with NarI and Bsu36I. The
construct encoding GST-Tbj1 behind the inducible GAL promoter (pWS900)
was created similarly but used a GST-YDJ1 expression vector (pWS523) obtained
from a different GST fusion library (19). pWS523 was linearized with NarI and
PstI. The constructs encoding other T. brucei Hsp40 proteins (Tbj2-4) behind the
constitutive phosphoglycerate kinase (PGK) promoter were also created by re-
combination using pWS28 linearized with XmaI as the recipient vector. PCR
products for the above constructs were derived from TREU 927 genomic DNA.
Candidate clones identified by restriction digest were sequenced to confirm the
presence of the appropriate Hsp40 gene.
Mating assay. The serial dilution yeast mating assay was performed as previ-
ously described (36). In brief, MATa yeast cells expressing the indicated CaaX
protease were cultured for 36 h at 30°C in selective media. The cultures were
normalized to an A600 of 1.0  0.05 by the addition of sterile media. The MAT
mating partner was cultured in YEPD and normalized in parallel using YEPD.
In wells of a 96-well microtiter plate, individual MATa strains were mixed with
MAT yeast using 10- and 90-l volumes, respectively, of each normalized
culture. The mating suspensions were serially diluted by repeatedly transferring
10 l of each mixture into a new well containing 90 l of MAT cells until five
dilutions were prepared. All mixtures were subsequently spotted (5-l volumes)
onto an SD plate, and the plates were incubated for 72 to 96 h before the results
were recorded by using a flatbed scanner. The cell suspensions were also spotted
onto SClysine solid media, which is selective for MATa and diploid growth, to
confirm that MATa cell dilutions were appropriately prepared.
GFP-Ras2p localization assay. An inducible GFP-Ras2p reporter (pWS750)
was used to determine the ability of yeast, human, and trypanosomal Rce1
(pWS479, pWS335, and pWS766, respectively) to promote proper localization of
GFP-Ras2p in yeast and to evaluate the effect of chemical agents on Ras2p
localization (28). Where yeast and trypanosomal Ste24 were evaluated, pSM1282
and pWS767 were used, respectively. In brief, mid-log yeast cells were harvested,
washed twice with sterile H2O, and incubated in SGalura for 6 to 7 h at 30°C
to induce expression of GFP-Ras2p. Where applicable, cells were incubated with
compounds that were sonicated prior to use with a Fisher Scientific model 100
sonic dismembrator (10 min, maximum setting) at predetermined concentrations
(0.6 to 55.6 M) for 1 h at 30°C. In general, the compounds were used at doses
where minimal cellular toxicity was observed (i.e., EC10; 90% cell survival). The
doses were based on previously reported dose-response toxicity profiles (S. P.
Manandhar, E. Hildebrandt, W. H. Jacobsen, G. Santangelo, and W. K. Schmidt,
unpublished data). Evaluation of compound 3 required the addition of a non-
toxic amount of sodium dodecyl sulfate (0.003%) during the incubation period to
maximize effectiveness. The induced cells were mounted on a microscope slide,
and the expression pattern of the GFP fusion was visualized by using a Zeiss
Axioskop 2 Mot Plus microscope equipped with fluorescence optics and a 100
Plan Apochromat objective lens (numerical aperture 1.4). Images were captured
by using an ORCA-AG digital camera (Hamamatsu, Japan) and IPLab Spectrum
software. At least five cell fields were taken from which representative images
were selected. Using the above protocol, ca. 80% of the cells examined demon-
strated GFP fluorescence.
To quantify the degree of GFP-Ras2p plasma membrane localization con-
ferred by CaaX proteases, a confocal laser scanning microscopy protocol was
implemented. In brief, yeast were cultured and induced to express GFP-Ras2p as
described above, and images were collected by using a Zeiss LSM510 META
microscope with a 100 alpha Plan Fluar 1.45 NA oil objective lens at a reso-
lution of 0.04 m per pixel. GFP excitation was performed with a 488-nm laser,
and the light was emitted was captured through a 505- to 530-nm BP filter. The
relative association of GFP-Ras2p with the plasma membrane was determined by
using Zeiss LSM imaging software from a minimum of five pictures and is
reported relative to the total fluorescence associated with the image. Delocalized
fluorescence was defined as fluorescence at0.75 m from the peak boundaries.
The error of the associated bar graphs was calculated as the standard error of the
mean for each value.
In vitro CaaX proteolysis fluorescence assay. Cleavage of a synthetic
quenched fluorogenic farnesylated peptide was used to monitor the in vitro
activity of the yeast, human, and trypanosomal CaaX proteases (21, 37). In brief,
a yeast strain devoid of endogenous CaaX protease activity (yWS164) was trans-
formed with a heterologous expression vector encoding a particular CaaX pro-
tease (as defined in the figure or table legends). The resulting transformants were
lysed and subjected to a differential centrifugation protocol optimized for the
recovery of CaaX protease-enriched membranes as described below. The mem-
branes (0.5 mg/ml) were incubated with a fluorogenic substrate (20 M), and the
relative fluorescence was monitored over a 90-min time course by using a BioTek
Synergy HT microtiter plate fluorometer equipped with a 320/420-nm excitation/
emission filter set. The substrates used were all internally quenched fluorogenic
peptides based on K-Ras4B (21).
Inhibitory compounds were evaluated by using two methods. To determine
values for percent inhibition of T. brucei Rce1 and T. brucei Ste24 using fixed
concentrations of compounds, membranes prepared as described below were
pretreated with compounds at 200 M (FKBK [Z-Phe-Lys-2,4,6-trimethylben-
zoyloxymethyl ketone], TPCK [tolylsulfonyl phenylalanyl chloromethyl ketone],
EDTA, and EGTA) or 100 M (all others) for 10 min at 30°C prior to substrate
addition and activity analysis. Compounds were typically prepared as 10 mM
stocks in water (EDTA and EGTA) or dimethyl sulfoxide (DMSO) (all others).
Collected data were graphed (as the change in fluorescence versus time), and
initial velocities were determined by using Microsoft Excel. These values were
used to calculate percent activities relative to an untreated DMSO control. To
determine 50% inhibitory concentration (IC50) values, the method described
above was modified so that each condition contained 2.8 mg of bovine serum
albumin/ml, and compound stocks were prepared at 100 mM in DMSO. Initial
velocities were determined at various inhibitor concentrations ranging from 0.46
to 471 M (11 points minimum). Compounds 1 to 9 were provided by the NCI
Developmental Therapeutics Program and are as previously identified (28).
Isolation of yeast membranes. Yeast membranes were essentially isolated as
previously described using two slightly modified protocols to lyse cells (37). In
general, membranes used for determination of the IC50 values and in vitro-
coupled proteolysis methylation assays were isolated directly from cells by bead
beating. In brief, mid-log cells were incubated in pretreatment buffer (100 mM
Tris [pH 9.4], 10 mM NaN3 10 mM dithiothreitol; 10 A600/ml) for 10 min,
resuspended in lysis buffer (50 mM Tris [pH 7.5], 0.2 M sorbitol, 1 mM EDTA,
1 mM phenylmethylsulfonyl fluoride, 2 g of aprotinin/ml, 3 g each of leupep-
tin, chymostatin, and pepstatin/ml; 500 A600/ml), and lysed by using a Biospec
mini-beadbeater and silica beads (5,000 rpm; three 20-s bursts; 3-min intervals on
ice). For all other in vitro assays, membranes were isolated from spheroplasts. In
brief, cells were pretreated as described above, and spheroplasts were generated
by treatment with Zymolyase (4 g/A600; Cape Cod, Inc.) for 30 min at 30°C in
spheroplasting buffer (50 mM potassium phosphate [pH 7.5], 1.4 M sorbitol, 10
mM NaN3; 25 A600/ml), followed by 10 min on ice. Spheroplasts were harvested
(3,000  g, 10 min, 4°C), washed in spheroplasting buffer, resuspended in cold
lysis buffer, and lysed by vortexing in the presence of silica beads (four 4-min
vortex bursts at 4°C; 2-min intervals on ice). Independent of the method used for
cell lysis, crude lysates were clarified twice (500  g, 10 min, 4°C), and mem-
branes were recovered (16,000  g, 15 min, 4°C) from the clarified lysate. The
membranes were resuspended in lysis buffer, reisolated by centrifugation, resus-
pended in lysis buffer to the original sample volume, adjusted to 1 mg of total
protein/ml by dilution with lysis buffer, and frozen as aliquots at 80°C.
In vitro Tbj1 proteolysis assay. TbJ1 (accession no. XP_951689) was heter-
ologously expressed as a GST fusion protein (pWS900) in SM3614 (rce1 ste24)
and used for coupled proteolysis-methylation radiolabeling assays. In brief, cells
from a 4-liter culture of yeast grown to an A600 of 	1.0 in SGalura were
harvested (3,000 g for 10 min) and incubated with pretreatment buffer, and the
cells were lysed directly as described above except that the lysis buffer was
supplemented with 20 g each of leupeptin, pepstatin, chymostatin, aprotinin,
and trypsin inhibitor/ml. The resulting lysate was clarified (16,000  g, 15 min)
and incubated with a slurry of glutathione-Sepharose 4B resin (10 min, 25°C,
0.675 ml of resin/liter of starting culture). The unbound fraction was decanted
after centrifugation of the mixture in a standard 15-ml conical tube.
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Resin-bound GST-Tbj1 was used directly for in vitro assays. In brief, the resin
was supplemented with 	800 l of lysis buffer, and the mixture was apportioned
into nine 300-l aliquots. Individual aliquots were supplemented with mem-
branes lacking CaaX protease activity (yWS164/pRS316) or enriched for a spe-
cific trypanosomal CaaX protease (yWS164/pWS766 or yWS164/pWS767) and
further supplemented with membranes enriched for the yeast ICMT (yWS164/
pSM1317). The final sample was 550 l and contained 0.54 mg of control or
CaaX protease-enriched membranes/ml and 0.11 mg of ICMT-enriched mem-
branes/ml. The membranes were isolated from cells lysed directly as described
above. The samples also contained 13.9 M S-adenosylmethionine (SAM; 19.6
mCi of 14C/mmol) derived by mixing appropriate amounts of SAM (Sigma) and
[14C]SAM (56 mCi/mmol; GE Healthcare). After constant mixing for 12 h at
30°C, the samples were transferred to individual spin columns (GE Healthcare),
centrifuged (1 min, 4,000  g), and washed three times with lysis buffer supple-
mented with 1% N-octyl-
-D-glucopyranoside, and the recovered resin was quan-
titatively transferred to scintillation vials containing 10 ml of Bio-Safe II scintil-
lation counting cocktail. Decays per minute were determined for each sample by
using a Fisher/GP-200 Wallac 1409 scintillation counter.
RESULTS
Both of the trypanosomal CaaX proteases are functional
enzymes. The yeast CaaX proteases promote yeast mating,
ostensibly through their ability to proteolyse the isoprenylated
yeast a-factor precursor (3). CaaX proteases from distinct spe-
cies can do the same when heterologously expressed in yeast
(4–6, 36). Since a previous study had concluded that T. brucei
Ste24 may be inactive, we first challenged T. brucei Rce1 and T.
brucei Ste24 to cleave the CVIA CaaX motif present on yeast
a-factor (20). This analysis revealed that the trypanosomal
CaaX proteases could both promote yeast mating, as judged by
quantitative serial dilution mating tests (Fig. 1A). This result
suggests that the lack of activity previously reported for T.
brucei Ste24 may be due to an assay specific or other issue, and
not reflective of the intrinsic properties of this enzyme. By our
analysis, the trypanosomal CaaX proteases performed as well
if not better than their respective yeast counterparts in pro-
moting yeast mating. In part, this observation can be explained
by the fact that the yeast and T. brucei CaaX proteases were
expressed using different plasmid systems. The yeast CaaX
proteases were encoded on low-copy plasmids behind their
respective promoters while the T. brucei CaaX proteases were
encoded on high-copy plasmids behind the strong constitutive
phosphoglycerate kinase promoter. Despite this issue, our re-
sult nonetheless indicates an activity for T. brucei Ste24 and
suggests that both T. brucei Rce1 and T. brucei Ste24, like their
counterparts in other organisms, have the common ability to
recognize the a-factor precursor as a substrate (3–6, 36).
Mutational analysis of the trypanosomal CaaX proteases.
To confirm that the mating observed in our genetic test was
indeed dependent on the proteolytic activities of the T. brucei
CaaX proteases and not some unrecognized activity, we next
evaluated the effect of mutations predicted to inactivate the
enzymes. Despite having a formally unresolved mechanism, a
glutamate and two histidine residues are known to be essential
for yeast Rce1p activity (12, 36). These residues are conserved
in Rce1p orthologs, including T. brucei Rce1, but their func-
tional importance in any ortholog outside of yeast had not
been previously addressed (35). Mutation of T. brucei Rce1 at
these conserved sites resulted in the loss of activity as mea-
sured by the yeast mating assay (Fig. 1B), further supporting a
role for histidine and glutamate residues in the Rce1p mech-
anism. In the instance of yeast Ste24p, histidine and glutamate
residues are also required (18). These amino acids are part of
a putative HExxH zinc-coordination motif that is common
among zinc-dependent metalloproteases. Expectedly, T. brucei
Ste24 required this motif for activity (Fig. 1C). For both T.
brucei CaaX proteases, the mutations had no observable effect
on protein expression relative to the native proteins, as judged
by immunoblots (D. Z. Mokry and W. K. Schmidt, unpublished
data). Our observations as a whole thus support that both T.
brucei Rce1 and T. brucei Ste24 have proteolytic activity.
Specificity of the trypanosomal CaaX proteases. To gain
additional insight into the enzymatic properties of the trypano-
somal CaaX proteases, we applied our genetic approach to
assess the target specificity of the enzymes by measuring their
ability to recognize disparate CaaX motifs (Fig. 1D). Variants
of the a-factor precursor were created that contained CaaX
motifs previously documented to be Rce1-specific (e.g., CTLM
and CTVM), Ste24-specific (e.g., CASQ), and nonspecific
(e.g., CVIA and CAMQ) in the context of CaaX proteases
from other species, namely, yeast and human (36, 47). Consis-
tent with these prior observations, T. brucei Rce1 was observed
to be specific for the CTLM and CTVM motifs, T. brucei Ste24
was specific for CASQ, and both were active against the native
CVIA motif (see Fig. 1A). The CAMQ motif was recognized
FIG. 1. Trypanosomal CaaX proteases promote yeast mating.
(A) Yeast wild type (WT) or strains lacking Rce1p and Ste24p were
evaluated for their ability to mate by using the serial dilution mating
test. The wild-type strain (EG123) was cotransformed with the empty
vectors marked with LEU2 (pRS315) and URA3 (pRS316). The CaaX
protease-deficient strain (yWS164) was cotransformed with an a-factor
encoding plasmid (pWS438) and a plasmid encoding the indicated
CaaX protease from trypanosome or yeast. The CaaX protease en-
coding plasmids were pSM1107, pSM1314, pWS766, and pWS767. (B
and C) Mutagenized forms of T. brucei Rce1 (B) and T. brucei Ste24
(C) were evaluated by the serial dilution mating test as described in
panel A. Only the first row of data from the mating test is shown. The
CaaX proteases were encoded in pWS766, pWS767, pWS798,
pWS800, pWS801, pWS802, pWS805, and pWS838. (D) Trypanoso-
mal, yeast, and human CaaX proteases were evaluated by the serial
dilution mating test as in panel A to assess their specificities against a
panel of CaaX motifs, some of which have previously been evaluated
and others that naturally occur on trypanosomal proteins (see the text
for details). Only the first row of data from the mating test is shown.
The CaaX proteases were encoded in pSM1107, pSM1314, pSM1585,
pWS335, pWS766, and pWS767. The a-factor variants were encoded in
pWS439, pWS440, pWS441, pWS442, pWS773, pWS774, pWS775,
pWS776, and pWS880.
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by both T. brucei CaaX proteases as predicted but was recog-
nized preferentially by T. brucei Ste24.
We extended our analysis to include an evaluation of motifs
associated with predicted trypanosomal CaaX proteins. Be-
cause trypanosomes do not appear to have a true Ras ortholog,
the CTML and CVIM motifs found on the Ras-related pro-
teins T. brucei RLP and T. brucei RHP, respectively, were
evaluated as targets for T. brucei Rce1 activity (17). Although
T. brucei Rce1 recognized both motifs, T. brucei Ste24 also
recognized CVIM, indicating that the T. brucei CaaX proteases
have overlapping specificity for this motif. Interestingly, CVIM
is found on mammalian Ras and is considered to be an Rce1p-
specific motif in mammalian systems. We also evaluated CaaX
motifs found on putative trypanosomal Hsp40 proteins. This
family of proteins was targeted because the CASQ motif,
which is present on the farnesylated Hsp40 chaperone Ydj1p,
is preferentially cleaved by various Ste24 orthologs in our ge-
netic system. None of these motifs (CTQQ, CVHQ, and
CTAQ) were cleaved by T. brucei Rce1, and only CVHQ was
cleaved by T. brucei Ste24. This pattern was also observed in
the context of yeast and human CaaX proteases, with the
exception of the CTAQ motif, which was readily cleaved by
Rce1 from these organisms. The reason for the lack of recog-
nition of the CTQQ (found on two trypanosomal homologs of
yeast Ydj1p) and CTAQ motifs by the T. brucei CaaX pro-
teases is unknown but may relate to the protein context in
which they were evaluated (see below and Discussion). When
considering our results as a whole and in the context of the
a-factor reporter, the trypanosomal CaaX proteases appear to
have substantial but not complete conservation of substrate
specificity with respect to that observed with CaaX proteases
from other systems.
Trypanosomal Rce1 can cleave a yeast GTPase. Both yeast
and human Rce1p preferentially, if not exclusively, recognize
GTPases of the Ras superfamily as substrates. Considering
that the T. brucei CaaX proteases displayed target specificity
profiles by our genetic test that were largely similar to the
profiles displayed by the yeast and human CaaX proteases, we
next evaluated whether T. brucei Rce1 had conserved the abil-
ity to recognize Ras GTPases as substrates. Attempts to het-
erologously express trypanosomal GTPases GFP-RLP and
GFP-RHP in yeast did not yield a discernible membrane as-
sociation for either GTPase, suggesting a potential defect with
isoprenylation, so we addressed the ability of T. brucei Rce1 to
interact with the yeast Ras2p GTPase. Ras2p normally deco-
rates the cytosolic face of the yeast plasma membrane (Fig.
2A). This localization pattern is highly dependent on the status
of Ras2p posttranslational processing (3, 28). In the absence of
CaaX protease activity (rce1 ste24), subcellular punctate
structures are observed with a GFP-Ras2p reporter (Fig. 2B).
As determined through qualitative and quantitative methods,
plasmid-based expression of yeast Rce1p, but not Ste24p, can
restore proper GFP-Ras2p localization in this genetic back-
ground (Fig. 2C and D, respectively, and Table 3). We took
advantage of this observation to investigate whether either of
the trypanosomal CaaX proteases could properly modify a
GTPase. When the trypanosomal CaaX proteases were evalu-
ated in the context of GFP-Ras2p, proper localization of the
reporter was observed with T. brucei Rce1 but not T. brucei
Ste24 (Fig. 2E and F, respectively, and Table 3).
Trypanosomal Hsp40 protein Tbj1 can substitute for yeast
Ydj1p and is cleaved by both Tb CaaX proteases. Primarily
through use of a-factor as a reporter molecule, the CaaX
proteases have been demonstrated to possess partially over-
lapping substrate specificity (47). However, the only two estab-
lished substrates for the Ste24p family of CaaX proteases are
the precursors of the yeast a-factor mating pheromone and
mammalian lamin A molecules. Since trypanosomes are not
known to express orthologs of either of these molecules and,
given the apparent specific ability of T. brucei Ste24 to cleave
FIG. 2. T. brucei Rce1 promotes proper Ras2p localization. Yeast
strains that were wild type (EG123) (A) or deficient for endogenous
yeast CaaX proteolytic activity (yWS164) (B to F) were each cotrans-
formed with a plasmid encoding a GFP-Ras2p reporter (pWS750) and
either an empty vector (A and B) or a plasmid encoding yeast Rce1p
(C), yeast Ste24p (D), T. brucei Rce1 (E), or T. brucei Ste24 (F). For
each condition, a small cluster of cells are shown as imaged after 6 h
of induction of the reporter in SGalura media. The CaaX proteases
were encoded in pSM1107, pSM1314, pWS766, and pWS767; pRS316
was used as the empty vector.
TABLE 3. Quantification of GFP-Ras2p plasma
membrane localization
Backgrounda CaaX protease % PMlocalization  SEMb
Wild type Vector 93.2  1.5
rce1 ste24 Vector 37.6  4.2
rce1 ste24 S. cerevisiae Rce1 80.7  1.2
rce1 ste24 T. brucei Rce1 83.0  1.4
rce1 ste24 S. cerevisiae Ste24 42.3  5.8
rce1 ste24 T. brucei Ste24 38.6  2.0
a Strains used were EG123 (wild type) or isogenic yWS164 (rce1 ste24) that
were cotransformed with plasmids encoding GFP-Ras2p (pWS750) and, as in-
dicated, an empty vector (pRS316) or plasmid encoding a CaaX protease
(pSM1107, pSM1314, pWS766, and pWS767).
b Values for plasma membrane (PM) localization were calculated as s/n,
where s is the sample standard deviation and n is number of observations.
VOL. 8, 2009 TRYPANOSOMATID CaaX PROTEASES HAVE DISTINCT ACTIVITIES 1895
 o
n
 Septem
ber 16, 2016 by guest
http://ec.asm
.org/
D
ow
nloaded from
 
CaaX motifs associated with Hsp40 proteins from different
organisms (i.e., CASQ of yeast Ydj1p and CVHQ of Tbj4), we
postulated that isoprenylated Hsp40 proteins are substrates of
Ste24p. In obvious conflict with this prediction is our observa-
tion that the T. brucei Hsp40-associated CaaX motifs CTQQ
and CTAQ fail to promote a-factor production when coex-
pressed with either trypanosomal CaaX protease (see Fig. 1D).
This leads to one of several possible hypotheses for these
motifs: either they are not bona fide CaaX motifs (i.e., isopre-
nylated), they are farnesylated but not proteolysed, or they
require a certain protein context in order to be recognized by
Ste24 (i.e., CTQQ and CTAQ are unrecognizable by Ste24 in
the context of yeast a-factor).
To differentiate between the above possibilities, we first de-
termined whether any T. brucei Hsp40 protein having a CaaX
motif could be isoprenylated by taking advantage of the obser-
vation that yeast are temperature sensitive when yeast Ydj1p is
either absent or fails to be isoprenylated (7). A query of the T.
brucei genome database yielded four putative Ydj1 orthologs,
herein referred to as Tbj1 to Tbj4 (accession numbers
XP_951689, XP_822483, XP_827509, and XP_845830, respec-
tively). The degrees of sequence identity relative to yeast
Ydj1p for Tbj1, Tbj2, Tbj3, and Tbj4 are 37, 18, 13, and 20%,
respectively, as determined by CLUSTAL W2 analysis. Heter-
ologous expression of Tbj1 and Tbj2 rescued growth of a ydj1
strain at elevated temperatures to an extent indistinguishable
from the wild type, Tbj3 rescued growth less robustly and, for
all practical purposes, Tbj4 failed to rescue growth (Fig. 3A).
Tbj1 and Tbj2 both possess the CTQQ CaaX motif, whereas
Tbj3 and Tbj4 possess the motifs CVHQ and CTAQ, respec-
tively. The inability of Tbj4 to complement growth was surpris-
ing, since it contains more sequence homology to yeast Ydj1p
than both Tbj2 and Tbj3. Sequence analysis of this clone and
others isolated independently during construction of the Tbj4
expression plasmid consistently revealed an 18-nucleotide de-
letion near the amino terminus. While this may be the cause
for the lack of complementation observed, it is also possible
that the sequence for this protein is incorrectly annotated
within the T. brucei genome database. The sequence we ob-
tained for this clone has been submitted to the National Center
for Biotechnology Information (accession no. FJ_611958).
To specifically determine the impact of protein farnesylation
on Tbj1 function, we mutated its CaaX motif cysteine to a
serine and evaluated the effect. Tbj1(C401S) could not rescue
the temperature sensitivity of the ydj1 yeast strain (Fig. 3B),
which is the same effect observed for yeast Ydj1p when simi-
larly mutated (7). We interpret this observation to indicate that
the function of Tbj1 in trypanosomes has an absolute require-
ment for the cysteine residue within the CTQQ motif, thereby
suggesting that Tbj1 is indeed isoprenylated.
To further test our hypothesis of protein context being im-
portant for specificity, we investigated whether T. brucei Rce1
and/or T. brucei Ste24 could cleave the CaaX motif of Tbj1
using a coupled proteolysis-carboxylmethylation assay. In this
type of assay, the extent of CaaX proteolytic activity is indi-
rectly monitored by the extent of ICMT-dependent carboxyl
methylation, which is monitored by using a radioactive tracer.
For the purposes of this experiment, the source of the Tbj1
substrate was a cell extract prepared from CaaX protease de-
ficient yeast that expressed Tbj1 heterologously. Although the
use of a purified form of the Tbj1 precursor would have been
preferred, attempts to purify an adequate quantity of Tbj1
from yeast cell extracts were unsuccessful due to the instability
of the precursor during purification. Use of the cell extract
revealed that both T. brucei CaaX proteases can cleave the
CTQQ motif of GST-TbJ1 (Table 4). This observation stands
in contrast to that observed for the cleavage of the CTQQ
motif in the context of the yeast a-factor reporter (see Fig. 1D),
which is not recognized by either T. brucei CaaX protease.
Hence, we propose that contextual information exists outside
the CaaX motif that aids in directing CaaX processing.
FIG. 3. Certain trypanosomal Hsp40 proteins rescue the tempera-
ture-sensitive phenotype of a Ydj1p-deficient yeast strain. (A) Inspec-
tion of the T. brucei genome identifies four trypanosomal Hsp40 pro-
teins (Tbj1, Tbj2, Tbj3, and Tbj4) with homology to the yeast Hsp40
protein Ydj1p. The trypanosomal enzymes were heterologously ex-
pressed in ydj1 yeast (yWS304), and individual strains were assessed
for growth at the indicated permissive and restrictive temperatures. In
the case of Tbj1 alone, it was expressed as a GST fusion. The plasmids
used were pWS782, pWS888, pWS889, and pWS890. (B) Plasmids
encoding GST fusions of Ydj1p, Tbj1, and Tbj1(C401S) were trans-
formed into ydj1 yeast (yWS304), and the transformed strains were
assessed, along with ydj1 yeast and the isogenic wild-type strain
(BY4741), for the ability to grow at the indicated temperatures. The
plasmids used were pWS338, pWS782, and pWS783.
TABLE 4. Coupled proteolysis-carboxyl methylation in vitro assay
reveals cleavage of Tbj1 by both T. brucei CaaX proteases
Protease cpma SEMb Pc
Vector 345.5 18.8
T. brucei Rce1 499.2 31.2 0.002
T. brucei Ste24 454.0 35.7 0.032
a Values represent mean of six data points derived from two independent exper-
iments (three replicates per experiment).
b The standard error of the mean was calculated from the equation s/n,
where s is sample standard deviation and n is number of observations.
c P values calculated by analysis of variance (single factor) relative to vector
condition.
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The trypanosomal CaaX proteases can be pharmacologi-
cally inhibited. Protein isoprenylation is considered a target
for antiparasitic drug discovery (13). Postisoprenylation en-
zymes appear to hold similar potential as drug discovery tar-
gets, as evidenced by the observation that RNAi-mediated
gene silencing of T. brucei Rce1 or T. brucei ICMT impairs the
growth of trypanosomes (20). Hence, we decided to determine
the inhibitor profiles of the trypanosomal CaaX proteases us-
ing in vitro and in vivo approaches with small molecules known
to inhibit CaaX proteases from other species (11, 12, 28).
For our in vitro approach, we first determined the utility of
K-Ras4B-based, internally quenched, fluorogenic peptide sub-
strates previously used to assess the function of the yeast and
human CaaX proteases (21, 28, 37). Our previous studies in-
dicated that quencher position within the CaaX motif can
specify cleavage by Rce1 or Ste24, which prefer quencher
placement at the a1 and X positions, respectively (37). We
predicted a similar result for the trypanosomal CaaX proteases
in part because of their differential ability to recognize a
GTPase CaaX motif (see Fig. 2) and our observation that yeast
and human orthologs have similar quencher position prefer-
ences (37; S. B. Porter and W. K. Schmidt, unpublished data).
Surprisingly, this prediction was not supported by our findings.
Unlike the profiles of yeast Rce1p and Ste24p, the trypanoso-
mal CaaX proteases had largely overlapping profiles, with both
proteases preferring the quencher at the X position (Fig. 4).
Using an optimized fluorogenic reporter (CVIQL), we eval-
uated the relative in vitro sensitivities of the trypanosomal
CaaX proteases to TPCK, a dipeptidyl (acyloxy)methyl ketone
(FKBK), EDTA, EGTA, and a set of small molecule com-
pounds previously demonstrated to inhibit yeast and human
Rce1p (28, 37). This analysis revealed that T. brucei Rce1 was
inhibited by all of the compounds, with the exception of EDTA
and EGTA (Table 5). The observed inhibitor profile of T.
brucei Rce1 was similar if not identical to that of yeast and
human Rce1p (28). Unlike its yeast and human counterparts,
T. brucei Ste24 was sensitive to TPCK. Otherwise, T. brucei
Ste24 behaved as predicted, being relatively insensitive to the
effects of EDTA, EGTA, weakly inhibited by compound 1, and
strongly inhibited by the other compounds evaluated. To gain
a more detailed understanding of the observed inhibitor effects
on T. brucei Rce1, we determined IC50 values for the small
molecule compound set (Table 6). The compounds largely had
IC50 values of 10 M, with the exception of compounds 2, 4,
and 5, which had IC50 values of 80 M.
We have observed that certain small molecule inhibitors
described above can induce delocalization of GFP-Ras2p in
vivo when applied to yeast cultures expressing yeast Rce1p and
that this phenotype is similar to that observed in the absence of
FIG. 4. Trypanosomal CaaX proteases have similar specificities to-
ward a synthetic K-Ras4B-based substrate. Yeast membranes enriched
for the indicated trypanosomal (A) or yeast (B) CaaX protease were
evaluated for their ability to cleave a farnesylated nonapeptide based
on the K-Ras4B C terminus. The peptide contains an amino benzoic
acid fluorophore that intensifies in fluorescence after cleavage of the
CaaX motif (CVIM), which contains a dinitrophenol quencher that is
coupled to a lysine (QL) placed at either the a1, a2, or X position. The
activity for each CaaX protease is reported relative to the condition
where maximal activity was observed. Closed bars represent Rce1
activity, and open bars represent Ste24 activity. The maximal activities
were 15.16 and 11.02 relative fluorescence units/min for trypanosomal
Rce1 and Ste24, respectively, and 93.27 and 25.10 relative fluorescence
units/min for yeast Rce1 and Ste24, respectively. All membrane sam-
ples were prepared in the SM3614 background. The plasmids used
were pSM1282, pWS479, pWS766, and pWS767.
TABLE 5. Inhibitor profiles of trypanosomal CaaX proteases
Compounda
Mean % activityb  SEM for:
T. brucei Rce1 T. brucei Ste24
TPCK 21.6  5.1 24.5  5.0
FKBK 34.4  6.0 30.0  3.5
EDTA 92.0  11.1 79.2  10.2
EGTA 94.6  5.5 75.7  3.2
1 30.7  4.8 59.4  5.9
2 22.1  4.7 24.1  5.3
3 18.6  2.7 14.9  5.8
4 23.9  9.5 31.3  10.9
5 34.2  9.4 35.1  8.6
6 19.3  4.0 28.0  2.4
7 18.4  3.8 28.6  2.2
8 16.1  3.3 14.6  5.4
9 15.4  3.7 20.6  3.8
a TPCK, FKBK, EDTA, and EGTA were used at 200 M. Compounds 1 to 9
are as previously identified and were used at 100 M (28).
b Values are relative to an appropriate untreated control treated with H2O
(EDTA and EGTA) or DMSO (TPCK, FKBK, compounds 1 to 9).
TABLE 6. IC50 values of Rce1p inhibitors observed with
trypanosomal and human Rce1
Species Compound Mean IC50(M)  SEM
T. brucei 1 3.24  0.52
2 83.42  7.18
3 8.10  3.21
4 160.75  14.21
5 176.77  34.16
6 1.30  0.07
7 0.25  0.22
8 4.23  1.46
9 0.91  0.13
H. sapiens 7 2.38  0.19
8 2.43  0.77
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CaaX protease activity (28). Thus, we predicted that chemical
treatment of yeast heterologously expressing trypanosomal
Rce1 as the only CaaX protease would result in a similar
phenotype. Indeed, six compounds induced delocalization
(Fig. 5A). Compounds 4 and 9 strongly induced delocalization,
with 91%, and 79% of the cell population responding, respec-
tively. Compounds 3, 6, 7, and 8 also induced delocalization,
but less dramatically, with 48, 47, 62 and 59% of the cell
population responding, respectively. Examples of the delocal-
ized patterns, regardless of being the majority or minority
phenotype, are shown in the respective panels of the figure.
Compounds 1, 2, and 5 had no effect on GFP-Ras2p localiza-
tion at the concentrations evaluated, which may represent a
lack of cell permeability by these compounds.
We were intrigued by the observation that compounds 7 and
8 could induce GFP-Ras2p delocalization, even if only in a
minority of the population, because of evidence suggesting that
human Rce1 was less sensitive to these compounds (28). To
further investigate the relative effects of these compounds on
trypanosomal and human Rce1, we performed both in vivo and
in vitro dose-response studies. Consistent with expectations, T.
brucei Rce1 was more sensitive to compounds 7 and 8 than
human Rce1 when evaluated using our GFP-Ras2p localiza-
tion assay (Fig. 5B). We observed that a 5.3 M concentration
of compound 7 was sufficient to induce delocalization of GFP-
Ras2p in the context of T. brucei Rce1, but this concentration
had no apparent effect on human Rce1. In fact, an 11.2 M
concentration of compound was required to delocalize the
reporter to the same extent in the context of human Rce1.
Similarly, a lower concentration of compound 8 was needed to
comparably delocalize GFP-Ras2p in the context of T. brucei
Rce1 compared to human Rce1 (10.8 and 25 M, respec-
tively). Consistent with our in vivo results, in vitro IC50 deter-
minations revealed that compound 7 was nearly 10-fold more
selective for T. brucei Rce1 than its human counterpart (Table
6). The opposite, however, was true for compound 8, which was
	2-fold less potent against T. brucei Rce1. The reason for the
lack of correlation with this compound is unknown. Together,
our observations indicate that GFP-Ras2p is an effective re-
porter for T. brucei Rce1 activity, that the subcellular distribu-
tion of GFP-Ras2p can be used as an indicator for determining
the effectiveness of compounds for disrupting T. brucei Rce1
activity in vivo, and that the reporter can be used to demon-
strate differential targeting specificity by Rce1 inhibitors (i.e.,
human versus trypanosomal Rce1).
DISCUSSION
The results of this study are consistent with the conclusion
that two separate CaaX protease activities are present in T.
brucei corresponding with genes encoding orthologs of Rce1p
and Ste24p found in other eukaryotic systems. This observa-
tion can be contrasted with that of a previous investigation into
the enzymatic properties of these proteins that revealed a
proteolytic activity in association with T. brucei Rce1 but not T.
brucei Ste24 (20). We propose that the lack of activity observed
in the earlier study for T. brucei Ste24 may be a direct conse-
quence of an inappropriate reporter for the enzyme. By our
own evidence, we find that T. brucei Ste24 is active against
several CaaX motifs when it is evaluated in the context of the
yeast a-factor reporter, including the CVIM motif present on
the substrate used in the prior trypanosomal study (Fig. 1).
From these observations, we hypothesize that contextual in-
formation is present within the non-CaaX portion of reporters
that helps specify T. brucei CaaX protease specificity. The idea
of contextual information being required by the CaaX pro-
teases has been previously proposed (47) and is further sup-
ported by our observation that CTQQ is suitable as a CaaX
motif in the context of Tbj1, but not yeast a-factor (Fig. 1D and
Table 4). Moreover, it has been demonstrated that yeast
Ste24p cannot cleave the CIIS motif in its natural protein
context (i.e., Ras2p), but can when appended to the a-factor
precursor (3, 47). Collectively, these observations challenge the
predictive utility of the a-factor reporter system, or any single
reporter background for that matter, as a means by which to
assess CaaX protease specificity.
Our most contextually correct data set for the T. brucei
CaaX proteases establishes that both can mediate maturation
of the T. brucei Hsp40-family protein Tbj1 (Table 4). However,
it would be inappropriate to extrapolate that Tbj2, Tbj3, and
Tbj4 are also processed in this manner because their CaaX
motifs have not been assessed in their proper protein context.
We also cannot infer that T. brucei Rce1 specifically mediates
maturation of the T. brucei RLP GTPase, despite an obvious
preference for cleavage of its CaaX motif (CTML) by T. brucei
Rce1 in our a-factor assay. Likewise, T. brucei Rce1 might
FIG. 5. Chemical agents can disrupt trypanosomal Rce1 activity in
vivo. (A) Effect of chemical agents on T. brucei Rce1 activity. yWS164
yeast expressing a GFP-Ras2p reporter and T. brucei Rce1 were tran-
siently treated for 1 h with DMSO (subpanel D) or the indicated
chemical agents prior to induction of GFP-Ras2p expression as de-
scribed in Fig. 2. Compounds were used at doses that were largely
nontoxic to liquid cultures of yeast (EC10). The EC10 doses for com-
pounds 3, 4, 6, 7, 8, and 9 were 7.89, 6.78, 0.67, 11.1, 10.8, and 3.78 M,
respectively. All others were used at 55.6 M. The plasmids used were
pWS750 and pWS766. (B) Dose-dependent effects of compounds 7
and 8 on human and trypanosomal Rce1. yWS164 yeast expressing a
GFP-Ras2p reporter (pWS750) and either the human (pWS335) or
trypanosomal (pWS766) Rce1 ortholog were evaluated for sensitivity
to compounds 7 and 8 by the protocol described in panel A using the
doses of compounds indicated. The percentage of cells with a delocal-
ized phenotype are reported from a minimum population of 60 cells
from at least three independent cell fields.
1898 MOKRY ET AL. EUKARYOT. CELL
 o
n
 Septem
ber 16, 2016 by guest
http://ec.asm
.org/
D
ow
nloaded from
 
specifically cleave T. brucei RHP despite its motif (CVIM)
being cleaved by both T. brucei CaaX proteases in our yeast
assay. It appears that determination of specific CaaX protease
processing preferences must be experimentally addressed on
an individual basis within their native context using methods
similar to those applied in this and other studies (4, 27, 34).
This will certainly be a challenging task given that inspection of
the T. brucei brucei genome using the TriTrypDB server reveals
over 200 proteins with a canonical CaaX motif, which can be
reduced to 61 by applying filters that eliminate pseudogenes,
hypothetical proteins, and those with putative signal sequences
that would not be expected to be associated with isoprenylated
CaaX proteins (see Table S1 in the supplemental material). It
remains to be determined which among these presumptive
CaaX proteins undergoes isoprenylation, let alone CaaX pro-
teolysis. Among the T. brucei GTPases previously identified,
only a few have CaaX motifs (17). These include the Ras-like
GTPase T. brucei RLP (CTML), the Rho-like GTPase T. bru-
cei RHP (CVIM), the Rab-like GTPase T. brucei Rab23
(CSVM), and the Rag-like GTPase T. brucei Rab28 (CAVM).
All other identified trypanosomal GTPases, including those of
the Arf and Ran families, do not contain CaaX motifs, while
additional members of the Rab family possess canonical dicys-
teine geranylgeranylation motifs. Future studies may ascertain
the role of T. brucei Rce1 and/or T. brucei Ste24 in the matu-
ration of trypanosomal GTPases containing a CaaX motif and
help elucidate the reported essential role of T. brucei Rce1
(20).
Our study cautions the use of a single reporter system to
specifically determine which CaaX protease cleaves a particu-
lar motif. Nonetheless, such reporters still retain value for
assessing whether a particular set of CaaX protease orthologs
has conserved or dissimilar specificity. For example, the obser-
vation that yeast and human Rce1p better recognize certain
motifs (Fig. 1D, CAMQ and CTAQ) than does T. brucei Rce1
in the context of the a-factor reporter implies that T. brucei
Rce1 has an intrinsic specificity difference from its relatives.
Similar arguments can be made for T. brucei Ste24 by compar-
ing its specificity profile to that of its orthologs, although the
observed differences are less dramatic (Fig. 1D, CASQ and
CAMQ).
The inhibition of T. brucei Rce1 could hold therapeutic
potential, since the loss of T. brucei Rce1 function appears to
be correlated with the loss of parasite viability (20); the impact
of Ste24 loss of function has not yet been addressed. Should
trypanosomal and human Rce1 ultimately have overlapping
substrate specificities, substrate-based inactivators of T. brucei
Rce1 will likely target the human enzyme, thereby leading to
unintended and undesirable side effects for patients. We have
observed some differences, however, in the activities of
trypanosomal and human Rce1 that may indicate that specific
targeting of the parasitic enzyme may be possible. First, we
determined that T. brucei Rce1 does not readily cleave CTAQ
and CAMQ motifs in the context of the a-factor reporter, and
thus does not have the exact specificity profile of its human and
yeast counterparts (Fig. 1D). Second, we observed that T.
brucei Rce1 has a distinct preference, by comparison to the
yeast and human enzymes, for the optimal placement of a
lysine dinitrophenol quenching group on a synthetic fluoro-
genic peptide reporter (Fig. 4) (37). Lastly, we identified two
small molecule agents that inhibit T. brucei Rce1 preferentially
over the human enzyme in vivo (Fig. 5). The specificity and
inhibitor profiles of T. brucei Rce1 seem to reflect enzymatic
differences between it and human Rce1, suggesting the exciting
prospect that trypanosome-specific agents can be identified
and developed. This conclusion is predicated on the observed
specificity differences holding true independent of protein con-
text.
In conclusion, our study continues to support the observa-
tion that eukaryotic systems generally possess two distinct
CaaX proteolytic activities. The purpose for this redundancy is
not immediately obvious and is likely tied to the need to ac-
commodate the great variety of substrate CaaX proteins en-
coded in eukaryotic genomes. We argue, based on our results,
that these substrates possess information both within their
CaaX motifs and protein backbones that provides specificity
for one or both proteolytic systems.
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